Free Trial
NASDAQ:ALVR

AlloVir (ALVR) Stock Price, News & Analysis

AlloVir logo
$2.61 +0.11 (+4.40%)
As of 07/7/2025

About AlloVir Stock (NASDAQ:ALVR)

Key Stats

Today's Range
$2.40
$2.61
50-Day Range
$2.36
$6.90
52-Week Range
$7.96
$24.15
Volume
14,700 shs
Average Volume
15,188 shs
Market Capitalization
$13.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter.

ALVR Stock News Headlines

Kalaris Announces Closing of Merger with AlloVir
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Kalaris, AlloVir announce stockholder approval of merger
Allovir's Vikas Sinha sells shares worth $3,052
See More Headlines

ALVR Stock Analysis - Frequently Asked Questions

AlloVir's stock was trading at $9.66 at the beginning of 2025. Since then, ALVR shares have decreased by 73.0% and is now trading at $2.61.

AlloVir, Inc. (NASDAQ:ALVR) issued its quarterly earnings results on Wednesday, August, 14th. The company reported ($1.15) EPS for the quarter, beating analysts' consensus estimates of ($2.30) by $1.15.

AlloVir's stock reverse split on Thursday, January 16th 2025.The 1-23 reverse split was announced on Wednesday, January 15th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

AlloVir (ALVR) raised $252 million in an initial public offering (IPO) on Thursday, July 30th 2020. The company issued 14,800,000 shares at $16.00-$18.00 per share. Morgan Stanley, J.P. Morgan, SVB Leerink and Piper Sandler acted as the underwriters for the IPO.

Shares of ALVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AlloVir investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/14/2024
Today
7/09/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALVR
CIK
1754068
Fax
N/A
Employees
110
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$190.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$29.35 per share
Price / Book
0.09

Miscellaneous

Free Float
3,425,000
Market Cap
$13.16 million
Optionable
Optionable
Beta
0.63
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ALVR) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners